Proceedings and Voting Results along with the Scrutinizer Report of 36th Annual General Meeting of Ganga Pharmaceuticals Limited held on Saturday, September 20, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals Ltd held its 36th Annual General Meeting on September 20, 2025, at its registered office in Virar (E), Palghar, from 12:00 noon to 12:35 PM. Of 369 shareholders on record, 11 attended in person (8 promoters, 3 public). All four resolutions passed with 100% approval, with 31,93,660 valid votes cast representing 54.02% of the 59,11,500 outstanding shares. The resolutions covered: (1) adoption of audited financial statements for FY ended March 31, 2025, (2) re-appointment of Mrs. Srijna Sharma as Director retiring by rotation, and special resolutions to appoint (3) Mr. Munna Baijnath Chaurasia and (4) Mr. Aman Mukesh Chaudhari as Independent Directors. There were zero dissenting votes and no invalid votes.
All resolutions passed unanimously, showing full shareholder support with no dissent. Public shareholder participation was very low at just 6.34% of public shares, but the outcome was driven by the promoter group which voted 100% of its 30.09 lakh shareholding. The addition of two new independent directors strengthens board composition. No material price impact expected as outcomes are largely procedural and in line with expectations.